Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
    about 2 days ago
  • Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
    about 2 days ago
  • New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
    about 2 days ago
  • A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
    about 3 days ago
  • New post on Science and Enterprise: A.I. Helps Visualize Emergency Social Media Data https://t.co/E94lXHnPsa #Science #Business
    about 3 days ago

Please share Science & Enterprise

Energy-Efficient Process Devised for Nano-Emulsions

Water drops

A more efficient process using less energy is being developed for producing emulsions with tiny droplets to deliver drugs or cosmetics through the skin. . . . → Read More: Energy-Efficient Process Devised for Nano-Emulsions

Synthetic Cannabidiol Shown to Reduce Seizures

Epilepsy graphic

A synthetic form of cannabidiol, or CBD, a derivative of cannabis, is shown in tests with lab rats to reduce the occurrence of seizures from epilepsy. . . . → Read More: Synthetic Cannabidiol Shown to Reduce Seizures

FDA Clears Wearable App Device for Migraine

Nerivio Migra patch

The Food and Drug Administration authorized a wearable nerve-stimulation device controlled by a mobile app to treat acute migraine headaches. . . . → Read More: FDA Clears Wearable App Device for Migraine

FDA Approves Rare Infant Disease Gene Therapy

Neurons

The Food and Drug Administration today approved a treatment for spinal muscular atrophy in young children that replaces a faulty gene in motor neurons with a healthy one. . . . → Read More: FDA Approves Rare Infant Disease Gene Therapy

Trial Shows Surgical Pain Managed Without Opioids

Head in hands

Results from a clinical trial show patients recovered from their hernia surgeries with non-opioid pain medications, and stayed off opioids for 15 days. . . . → Read More: Trial Shows Surgical Pain Managed Without Opioids

FDA Issues Final Biosimilar Guidance

Pills and dollar bill

The Food and Drug Administration issued its final guidance on regulating the interchangeability of so-called biosimilars with original biologic drugs. . . . → Read More: FDA Issues Final Biosimilar Guidance

Trial Testing Heart Device Outcomes by Gender

Heart check

A clinical trial is underway tracking patients with implanted heart devices for 3 years to find any differences in health outcomes between men and women. . . . → Read More: Trial Testing Heart Device Outcomes by Gender

Kidney Diagnostics Receive FDA Breakthrough Tag

Data and person graphic

An algorithm-driven diagnostic test for chronic kidney disease is receiving a breakthrough device designation from the Food and Drug Administration. . . . → Read More: Kidney Diagnostics Receive FDA Breakthrough Tag

FDA Approves Transplant Lung Preservation System

Human lungs illustration

The Food and Drug Administration approved a medical device that restores and maintains lungs for transplants that may not otherwise be acceptable. . . . → Read More: FDA Approves Transplant Lung Preservation System

Gel Boosts T-Cells for Cancer Treatments

T-cells illustration

A biomedical engineering team devised techniques using a gel to produce more engineered T-cells, which in lab mice stopped the growth of tumors. . . . → Read More: Gel Boosts T-Cells for Cancer Treatments